Loading
Christopher VanDeusen

Christopher VanDeusen

Chief Scientific Officer, Artax Biopharma
United States
Chris VanDeusen, Ph.D. brings more than 20 years of experience in the biopharmaceutical sector, with extensive expertise in drug discovery and development having contributed to or been the inventor of multiple compounds entering into pre-clinical development. Previously, Dr. VanDeusen was the head of the Chemistry division within Tissue Protection and Repair at Sanofi and Genzyme, leading global project teams in the areas of inflammation and fibrosis. Dr. VanDeusen earned a BA in Chemistry from Wittenberg University and a PhD from Stanford University.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS